<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.psychosomaticmedicine.org">
<title>Psychosomatic Medicine current issue</title>
<link>http://www.psychosomaticmedicine.org</link>
<description>Psychosomatic Medicine RSS feed -- current issue</description>
<prism:eIssn>1534-7796</prism:eIssn>
<prism:coverDisplayDate>February/March  2010</prism:coverDisplayDate>
<prism:publicationName>Psychosomatic Medicine</prism:publicationName>
<prism:issn>0033-3174</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/107?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/113?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/122?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/128?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/134?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/141?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/148?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/156?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/163?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/172?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/178?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/187?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/192?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/198?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/206?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/215?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/224?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/226?rss=1" />
  <rdf:li rdf:resource="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/227?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://www.psychosomaticmedicine.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://www.psychosomaticmedicine.org/icons/banner/title.gif">
<title>Psychosomatic Medicine</title>
<url>http://www.psychosomaticmedicine.org/icons/banner/title.gif</url>
<link>http://www.psychosomaticmedicine.org</link>
</image>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/107?rss=1">
<title><![CDATA[Social Influences on Health: Is Serotonin a Critical Mediator?]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/107?rss=1</link>
<description><![CDATA[
<p>The influence of social relationships on health has been well documented for many years, yet identifying the physiological mechanisms responsible for these effects has proved more challenging. This review assesses the potential role of the serotonin system in affecting sensitivity to the health-related effects of the social environment. Building on recent studies of genetic variation in the serotonin system, particularly focusing on a polymorphism (5-HTTLPR) in the serotonin transporter gene, we provide evidence that activity within the serotonin system is critically involved in setting sensitivity to social experiences. Furthermore, we highlight the effects of the 5-HTTLPR on sensitivity to both positive and negative social experiences. In a positive environment, individuals with the short allele, and particularly the short/short genotype, function better psychologically than those with the long/long genotype. Conversely, when exposed to adverse environments or in the absence of social support, individuals with the short allele are at high risk for a variety of negative health outcomes. This serotoninergic involvement in social sensitivity seems to occur in concert with other neurochemical systems, such as the opioid system, which will also be discussed. Although this differential sensitivity to social experiences is initially determined in the brain, it has physiological effects on downstream pathways that more directly affect disease mechanisms, such as the hypothalamic-pituitary-adrenal axis, which is a particular focus of this review. The serotonin system, as indexed by the 5-HTTLPR, is an important link between the social environment and health.</p>
]]></description>
<dc:creator><![CDATA[Way, B. M., Taylor, S. E.]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Social Support, Genetics, Reviews]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181ce6a7d</dc:identifier>
<dc:title><![CDATA[Social Influences on Health: Is Serotonin a Critical Mediator?]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>112</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>107</prism:startingPage>
<prism:section>CUTTING-EDGE REVIEW</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/113?rss=1">
<title><![CDATA[Stress, Inflammation, and Yoga Practice]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/113?rss=1</link>
<description><![CDATA[
<p><b>Objective: </b> To address the mechanisms underlying hatha yoga&rsquo;s potential stress-reduction benefits, we compared inflammatory and endocrine responses of novice and expert yoga practitioners before, during, and after a restorative hatha yoga session, as well as in two control conditions. Stressors before each of the three conditions provided data on the extent to which yoga speeded an individual&rsquo;s physiological recovery.</p>
<p><b>Methods: </b> A total of 50 healthy women (mean age, 41.32 years; range, 30&ndash;65 years), 25 novices and 25 experts, were exposed to each of the conditions (yoga, movement control, and passive-video control) during three separate visits.</p>
<p><b>Results: </b> The yoga session boosted participants&rsquo; positive affect compared with the control conditions, but no overall differences in inflammatory or endocrine responses were unique to the yoga session. Importantly, even though novices and experts did not differ on key dimensions, including age, abdominal adiposity, and cardiorespiratory fitness, novices&rsquo; serum interleukin (IL)-6 levels were 41% higher than those of experts across sessions, and the odds of a novice having detectable C-reactive protein (CRP) were 4.75 times as high as that of an expert. Differences in stress responses between experts and novices provided one plausible mechanism for their divergent serum IL-6 data; experts produced less lipopolysaccharide-stimulated IL-6 in response to the stressor than novices, and IL-6 promotes CRP production.</p>
<p><b>Conclusion: </b> The ability to minimize inflammatory responses to stressful encounters influences the burden that stressors place on an individual. If yoga dampens or limits stress-related changes, then regular practice could have substantial health benefits.</p>
]]></description>
<dc:creator><![CDATA[Kiecolt-Glaser, J. K., Christian, L., Preston, H., Houts, C. R., Malarkey, W. B., Emery, C. F., Glaser, R.]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Endocrinology, Exercise, Immunology, Stress and Coping]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181cb9377</dc:identifier>
<dc:title><![CDATA[Stress, Inflammation, and Yoga Practice]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>121</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>113</prism:startingPage>
<prism:section>ORIGINAL ARTICLES</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/122?rss=1">
<title><![CDATA[Adverse Impact of Mood on Flow-Mediated Dilation]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/122?rss=1</link>
<description><![CDATA[
<p><b>Objective: </b> To examine the impact of mood states on endothelial function, as measured noninvasively by brachial artery flow-mediated dilation (FMD). Substantial literature indicates that negative mood is linked to cardiovascular disease (CVD). However, the mechanisms underlying this relationship are not well defined. CVD is often preceded by dysfunction of the endothelium.</p>
<p><b>Methods: </b> Healthy adults (<I>n</I> = 70; mean age, 36 years) completed the Profile of Mood States (POMS), which contains six subscales (depression/dejection; tension/anxiety; anger/hostility; confusion/bewilderment; fatigue/inertia; vigor/activity) that are used to compute a total mood disturbance score for overall psychological distress. FMD was calculated (maximum percentage change in brachial artery diameter) from ultrasound assessment of arterial diameter at baseline and for 10 minutes after occlusion.</p>
<p><b>Results: </b> Regressions showed that increases in POMS total mood disturbance scores were associated with decreases in endothelial function. Mood disturbance explained 10% of the variance in FMD (<I>p</I> &lt; .01), after controlling for age, sex, mean arterial pressure, body mass index, and socially desirable response bias. An exploratory set of separate regressions conducted to decompose the link between FMD and total mood disturbance revealed that the following POMS subscales were inversely correlated with FMD: depression/dejection, tension/anxiety, anger/hostility, fatigue/inertia (<I>p</I>&rsquo;s &lt; .05), and confusion/bewilderment (<I>p</I> &lt; .01).</p>
<p><b>Conclusions: </b> Mood disturbance could contribute to CVD via impaired vasodilation. These preliminary results show that even mild levels of adverse psychological states, particularly depressed, anxious, angry, confused, and fatigued states, might be linked to increased cardiovascular risk.</p>
]]></description>
<dc:creator><![CDATA[Cooper, D. C., Milic, M. S., Tafur, J. R., Mills, P. J., Bardwell, W. A., Ziegler, M. G., Dimsdale, J. E.]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Anxiety, Depression, Other Cardiovascular Medicine]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181cdbfc0</dc:identifier>
<dc:title><![CDATA[Adverse Impact of Mood on Flow-Mediated Dilation]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>127</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>122</prism:startingPage>
<prism:section>ORIGINAL ARTICLES</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/128?rss=1">
<title><![CDATA[Heart Rate Recovery After Cognitive Challenge Is Preserved With Age]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/128?rss=1</link>
<description><![CDATA[
<p><b>Objective: </b> To investigate the effect of age on heart rate recovery (HRR) from cognitive challenge.</p>
<p><b>Background: </b> Aging is an independent risk factor for the development of cardiovascular disease. HRR from exercise is an established predictor of cardiac morbidity and mortality, and evidence suggests that HRR from cognitive challenge is predictive of cardiac morbidity as well. Aging is associated with delayed HRR from exercise stress, but little is known about the effect of aging on HRR from psychological stress. We tested the hypothesis that age would be related to delayed HRR from psychological stress.</p>
<p><b>Methods: </b> HRR post exposure to cognitive challenge (mental arithmetic and Stroop) was investigated in a sample of 436 participants aged 35 to 84 years in MIDUS II, a national study of health and well-being. HRR was measured as 1) the amount of change from the stress level; 2) time to recover; and 3) the area under the curve. The analyses were controlled for medical comorbidities and medications that influence HR, such as body mass index, smoking, sex, menopausal status, and amount of physical activity/exercise.</p>
<p><b>Results: </b> There was no effect for age on HRR as evaluated by all three recovery assessment methods.</p>
<p><b>Conclusions: </b> Contrary to expectation and in contrast to findings concerning HRR from exercise, HRR from cognitive challenge was preserved with age. These findings require further inquiry into differential mechanism(s) underlying HRR from psychological versus exercise stress, including any role for improved emotion regulation with greater age.</p>
]]></description>
<dc:creator><![CDATA[Shcheslavskaya, O. V., Burg, M. M., McKinley, P. S., Schwartz, J. E., Gerin, W., Ryff, C. D., Weinstein, M., Seeman, T. E., Sloan, R. P.]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Aging, Parasympathetic Nervous System, Psychophysiology, Sympathetic Nervous System, Other Cardiovascular Medicine]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181c94ca0</dc:identifier>
<dc:title><![CDATA[Heart Rate Recovery After Cognitive Challenge Is Preserved With Age]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>133</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>128</prism:startingPage>
<prism:section>ORIGINAL ARTICLES</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/134?rss=1">
<title><![CDATA[Association of Optimism and Pessimism With Inflammation and Hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA)]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/134?rss=1</link>
<description><![CDATA[
<p><b>Objective: </b> To investigate the association between optimism/pessimism and concentrations of seven inflammation and hemostasis markers. Optimism and pessimism are associated with cardiovascular disease mortality and progression; however, the biological mechanism remains unclear.</p>
<p><b>Methods: </b> This cross-sectional study used data from the Multi-Ethnic Study of Atherosclerosis (MESA), a study of 6814 persons aged 45 to 84 years with no history of clinical cardiovascular disease. The Life-Orientation Test-Revised (LOT-R) was used to measure dispositional optimism and pessimism. Regression analyses were used to estimate associations of optimism and pessimism with interleukin (IL)-6, C-reactive protein (CRP), fibrinogen, homocysteine, Factor VIII, D-dimer, and plasmin-antiplasmin, before and after adjustment for sociodemographics, depression, cynicism, health behaviors, body mass index (BMI), hypertension, and diabetes.</p>
<p><b>Results: </b> Higher scores on the LOT-R (positive disposition) were related to lower concentrations of IL-6 (<I>p</I> = .001), fibrinogen (<I>p</I> &lt; .001), and homocysteine (<I>p</I> = .031). Associations were stronger for the pessimism subscale. After adjustment for demographics, the percentage differences in inflammatory markers corresponding to a 2-standard deviation increase in pessimism were 6.01% (<I>p</I> = .001) for IL-6, 10.31% (<I>p</I> = .001) for CRP, 2.47% (<I>p</I> &lt; .0001) for fibrinogen, and 1.36% (<I>p</I> = .07) for homocysteine. Associations were attenuated but significant after adjustment for sociodemographics, depression, cynical distrust, and behaviors. Further adjustment for hypertension, BMI, and diabetes reduced associations for CRP and IL-6. Pessimism remained associated with a 1.36% (<I>p</I> = .02) increase in fibrinogen in the fully adjusted model. Factor VIII, D-dimer, and plasmin-antiplasmin were not associated with the LOT-R or subscales.</p>
<p><b>Conclusions: </b> Pessimism is related to higher levels of inflammation. Health behaviors, BMI, hypertension, and diabetes seem to play a mediating role.</p>
]]></description>
<dc:creator><![CDATA[Roy, B., Diez-Roux, A. V., Seeman, T., Ranjit, N., Shea, S., Cushman, M.]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Immunology, Personality, Coronary Artery Disease]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181cb981b</dc:identifier>
<dc:title><![CDATA[Association of Optimism and Pessimism With Inflammation and Hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA)]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>140</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>134</prism:startingPage>
<prism:section>ORIGINAL ARTICLES</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/141?rss=1">
<title><![CDATA[Socioeconomic Status Moderates the Association Between John Henryism and NEO PI-R Personality Domains]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/141?rss=1</link>
<description><![CDATA[
<p><b>Objective: </b> To investigate associations between John Henryism (JH) and NEO Personality Inventory-Revised (PI-R) personality domains. JH&mdash;a strong behavioral predisposition to engage in high-effort coping with difficult psychosocial and economic stressors&mdash;has been associated with poor health, particularly among persons in lower socioeconomic (SES) groups. Unfavorable personality profiles have also been frequently linked to poor health; however, no studies have yet examined what global personality traits characterize JH.</p>
<p><b>Methods: </b> Hypotheses were examined, using data from a sample of 233 community volunteers (mean age, 33 years; 61% black and 39% white) recruited specifically to represent the full range of the SES gradient. Personality (NEO PI-R) and active coping (12-item JH scale) measures and covariates were derived from baseline interviews.</p>
<p><b>Results: </b> In a multiple regression analysis, independent of SES, JH was positively associated with Conscientiousness (C) (<I>p</I> &lt; .001) and Extraversion (E) (<I>p</I> &lt; .001), whereas the combination of low JH and high SES was associated with Neuroticism (N) (<I>p</I> = .02) When examining associations between JH and combinations of NEO PI-R domains called "styles," high JH was most strongly associated with a high E/high C "Go-Getters" style of activity, whereas low JH was associated with the low E/high Openness (O) "Introspectors" style. In facet level data, the most robust associations with JH were found for five C and five E facets.</p>
<p><b>Conclusions: </b> High JH was associated with higher scores on C and E, but the combination of low JH and high SES was associated with higher scores on N.</p>
]]></description>
<dc:creator><![CDATA[Stanton, M. V., Jonassaint, C. R., Williams, R. B., James, S. A.]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Social Class, Personality, Stress and Coping, Blood Pressure]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181cdc00e</dc:identifier>
<dc:title><![CDATA[Socioeconomic Status Moderates the Association Between John Henryism and NEO PI-R Personality Domains]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>147</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>141</prism:startingPage>
<prism:section>ORIGINAL ARTICLES</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/148?rss=1">
<title><![CDATA[Quality of Parental Emotional Care and Calculated Risk for Coronary Heart Disease]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/148?rss=1</link>
<description><![CDATA[
<p><b>Objective: </b> To evaluate associations between perceived quality of parental emotional care and calculated 10-year risk for coronary heart disease (CHD). Little is understood about the role of parental emotional care in contributing to the risk for CHD.</p>
<p><b>Methods: </b> The study sample was composed of 267 participants from the New England Family Study. Quality of parental emotional care was measured, using a validated short version of the Parental Bonding Instrument (PBI) as the average care scores for both parents (range = 0&ndash;12), with higher scores indicating greater care. Ten-year CHD risk was calculated, using the validated Framingham Risk Algorithm that incorporates the following prevalent CHD risk factors: age, sex, diabetes, smoking, total cholesterol, high-density lipoprotein cholesterol, and blood pressure. Multiple linear regression assessed associations of PBI with calculated CHD risk after adjusting for childhood socioeconomic status, depressive symptomatology, educational attainment, and body mass index.</p>
<p><b>Results: </b> Among females, a 1-unit increase in the parental emotional care score resulted in a 4.6% (<I>p</I> = .004) decrease in the 10-year CHD risk score, after adjusting for covariates. There was no association between parental emotional care score and calculated CHD risk score in males (<I>p</I> = .22).</p>
<p><b>Conclusion: </b> Quality of parental emotional care was inversely associated with calculated 10-year CHD risk in females, and not males. Although the gender differences need further investigation and these findings require replication, these results suggest that the early childhood psychosocial environment may confer risk for CHD in adulthood.</p>
]]></description>
<dc:creator><![CDATA[Almeida, N. D., Loucks, E. B., Kubzansky, L., Pruessner, J., Maselko, J., Meaney, M. J., Buka, S. L.]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Social Support, Pediatrics, Coronary Artery Disease]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181c925cb</dc:identifier>
<dc:title><![CDATA[Quality of Parental Emotional Care and Calculated Risk for Coronary Heart Disease]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>155</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>148</prism:startingPage>
<prism:section>ORIGINAL ARTICLES</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/156?rss=1">
<title><![CDATA[Impact of Early Parental Child-Rearing Behavior on Young Adults' Cardiometabolic Risk Profile: A Prospective Study]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/156?rss=1</link>
<description><![CDATA[
<p><b>Objective: </b> To examine prospectively whether early parental child-rearing behavior is a predictor of cardiometabolic outcome in young adulthood when other potential risk factors are controlled. Metabolic factors associated with increased risk for cardiovascular disease have been found to vary, depending on lifestyle as well as genetic predisposition. Moreover, there is evidence suggesting that environmental conditions, such as stress in pre- and postnatal life, may have a sustained impact on an individual&rsquo;s metabolic risk profile.</p>
<p><b>Methods: </b> Participants were drawn from a prospective, epidemiological, cohort study followed up from birth into young adulthood. Parent interviews and behavioral observations at the age of 3 months were conducted to assess child-rearing practices and mother-infant interaction in the home setting and in the laboratory. In 279 participants, anthropometric characteristics, low-density lipoprotein and high-density lipoprotein cholesterol, apolipoproteins, and triglycerides were recorded at age 19 years. In addition, structured interviews were administered to the young adults to assess indicators of current lifestyle and education.</p>
<p><b>Results: </b> Adverse early-life interaction experiences were significantly associated with lower levels of high-density lipoprotein cholesterol and apolipoprotein A1 in young adulthood. Current lifestyle variables and level of education did not account for this effect, although habitual smoking and alcohol consumption also contributed significantly to cardiometabolic outcomes.</p>
<p><b>Conclusions: </b> These findings suggest that early parental child-rearing behavior may predict health outcome in later life through its impact on metabolic parameters in adulthood.</p>
]]></description>
<dc:creator><![CDATA[Buchmann, A. F., Kopf, D., Westphal, S., Lederbogen, F., Banaschewski, T., Esser, G., Schmidt, M. H., Zimmermann, U. S., Laucht, M., Deuschle, M.]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Social Support, Stress and Coping, Other Cardiovascular Medicine]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181c88343</dc:identifier>
<dc:title><![CDATA[Impact of Early Parental Child-Rearing Behavior on Young Adults' Cardiometabolic Risk Profile: A Prospective Study]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>162</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>156</prism:startingPage>
<prism:section>ORIGINAL ARTICLES</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/163?rss=1">
<title><![CDATA[Clustering of Negative Affectivity and Social Inhibition in the Community: Prevalence of Type D Personality as a Cardiovascular Risk Marker]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/163?rss=1</link>
<description><![CDATA[
<p><b>Objective: </b> To explore the prevalence of Type D personality&mdash;the combination of negative affectivity and social inhibition&mdash;in the general population and its relationship to other cardiovascular risk factors, including psychopathological symptoms. Type D personality has been identified as a prognostic risk factor for various cardiovascular disease conditions.</p>
<p><b>Methods: </b> In a representative sample of 2698 individuals (aged 35&ndash;74 years), psychological, lifestyle, and somatic risk factors were investigated with laboratory testing, self-report measures, and a clinical interview. Type D was assessed with the German Type D Scale-14.</p>
<p><b>Results: </b> The prevalence of Type D was 23.4% (95% confidence interval [CI], 21.2&ndash;25.6) in men and 26.9% (95% CI, 23.7&ndash;30.1) in women and, thus, in the range of classical risk factors (e.g., hypercholesterolemia). In age-adjusted analysis, Type D was associated with psychopathological symptoms, including depression and somatic symptom burden. With the exception of physical inactivity in both sexes, hypertension in women and hypercholesterolemia in men, Type D was not associated with classical cardiovascular risk factors. Multivariate analysis revealed depression, exhaustion, anxiety, and low self-rated health as associated with Type D in both sexes (odds ratios, 1.97&ndash;3.21 in men, 1.52&ndash;2.44 in women).</p>
<p><b>Conclusions: </b> A Type D personality disposition can be found in about a quarter of the general population, which is comparable to the prevalence of classical cardiovascular risk factors. In both sexes, an independent association to Type D appeared mainly in psychopathological symptoms. Type D constitutes a relevant and independent risk marker in the community and should receive attention in clinical practice.</p>
]]></description>
<dc:creator><![CDATA[Hausteiner, C., Klupsch, D., Emeny, R., Baumert, J., Ladwig, K.-H., for the KORA Investigators]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Personality, Other Cardiovascular Medicine]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181cb8bae</dc:identifier>
<dc:title><![CDATA[Clustering of Negative Affectivity and Social Inhibition in the Community: Prevalence of Type D Personality as a Cardiovascular Risk Marker]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>171</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>163</prism:startingPage>
<prism:section>ORIGINAL ARTICLES</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/172?rss=1">
<title><![CDATA[Rationale and Design of a Randomized Clinical Trial Comparing Stress Reduction Treatment to Usual Cardiac Care: The Reducing Vulnerability to Implantable Cardioverter Defibrillator Shock-Treated Ventricular Arrhythmias (RISTA) Trial]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/172?rss=1</link>
<description><![CDATA[
<p><b>Objective: </b> To present the design of a multicenter, randomized trial testing the effects of stress reduction treatment (SRT) on the prevalence of shock-treated ventricular arrhythmias among patients with an implantable cardioverter defibrillator (ICD). Significant adjustment problems secondary to ICD shock can increase the likelihood of arrhythmias requiring shock for termination. Whether SRT can reduce arrhythmias requiring shock for termination in patients with ICDs has not been tested in clinical trials.</p>
<p><b>Methods: </b> New ICD recipients and previous recipients who have received an appropriate therapeutic shock in the last 6 months (<I>n</I> = 304) will be enrolled and randomized to either SRT or usual cardiac care. Participants complete a psychosocial questionnaire and undergo laboratory mental stress testing and 24-hour Holter monitoring with diary at study entry and approximately 4 months later. Follow-ups are completed at 6, 12, and 24 months post randomization to assess occurrence of ICD shock for ventricular arrhythmias (primary outcome), antitachycardia pacing events, medication changes, hospitalizations, deaths, and quality of life.</p>
<p><b>Results: </b> Log-rank test and Cox proportional hazards model will be used to test the effects of SRT on time to first shock-treated ventricular arrhythmia, with exploratory analyses testing the effects on overall frequency of ventricular arrhythmia. Secondary analyses will test the effects of SRT on laboratory stress-induced and 24-hour arrhythmogenic electrophysiological indices from pre to post treatment, and both quality of life and measures of anger across the 2 years of the study.</p>
<p><b>Conclusions: </b> The Reducing Vulnerability to ICD Shock-Treated Ventricular Arrhythmias (RISTA) Trial is the first large-scale, randomized, clinical trial designed to evaluate the effect of SRT on the prevalence of shock-treated arrhythmias among patients with an ICD. Results may demonstrate a treatment that can reduce vulnerability to arrhythmia-provoked shock and improve quality of life.</p>
]]></description>
<dc:creator><![CDATA[Donahue, R. G., Lampert, R., Dornelas, E., Clemow, L., Burg, M. M., For the RISTA Investigators]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Stress and Coping, Therapeutic Interventions, Other Cardiovascular Medicine]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181c932d4</dc:identifier>
<dc:title><![CDATA[Rationale and Design of a Randomized Clinical Trial Comparing Stress Reduction Treatment to Usual Cardiac Care: The Reducing Vulnerability to Implantable Cardioverter Defibrillator Shock-Treated Ventricular Arrhythmias (RISTA) Trial]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>177</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>172</prism:startingPage>
<prism:section>ORIGINAL ARTICLES</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/178?rss=1">
<title><![CDATA[Protecting Sleep, Promoting Health in Later Life: A Randomized Clinical Trial]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/178?rss=1</link>
<description><![CDATA[
<p><b>Objectives: </b> To determine in healthy people aged &ge;75 years 1) if restricting time in bed and education in health sleep practices are superior to an attention-only control condition (i.e., education in healthy dietary practices) for maintaining or enhancing sleep continuity and depth over 2.5 years; and 2) if maintenance or enhancement of sleep continuity and depth promotes the maintenance or enhancement of health-related quality of life.</p>
<p><b>Methods: </b> Single-blind, randomized, clinical trial in a university-based sleep center, enrolling 64 adults (<I>n</I> = 30 women, 34 men; mean age = 79 years) without sleep/wake complaints (e.g., insomnia or daytime sleepiness), followed by randomized assignment to either: 1) restriction of time in bed by delaying bedtime 30 minutes nightly for 18 months, together with education in healthy sleep practices (SLEEP); or 2) attention-only control condition with education in health dietary practices (NUTRITION).</p>
<p><b>Results: </b> SLEEP did not enhance sleep continuity or depth; however, compared with NUTRITION, SLEEP was associated with decreased time spent asleep (about 30 minutes nightly over 18 months). Contrary to hypothesis, participants in SLEEP reported a decrement in physical health-related quality of life and an increase in medical burden (cardiovascular illness), relative to NUTRITION. Neither markers of inflammation, body mass index, or exercise explained treatment-related changes in medical burden.</p>
<p><b>Conclusions: </b> Although we cannot exclude a positive effect of education in healthy nutrition, for healthy elderly &gt;75 years of age without sleep complaints, reducing sleep time may be detrimental, whereas allowing more time to sleep (about 7.5 hours nightly) is associated with better maintenance of physical health-related quality of life and stability of medical illness burden over 30 months.</p>
]]></description>
<dc:creator><![CDATA[Reynolds, C. F., Serody, L., Okun, M. L., Hall, M., Houck, P. R., Patrick, S., Maurer, J., Bensasi, S., Mazumdar, S., Bell, B., Nebes, R. D., Miller, M. D., Dew, M. A., Nofzinger, E. A.]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Aging, Sleep and Biological Rhythms]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181c870a5</dc:identifier>
<dc:title><![CDATA[Protecting Sleep, Promoting Health in Later Life: A Randomized Clinical Trial]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>186</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>178</prism:startingPage>
<prism:section>ORIGINAL ARTICLES</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/187?rss=1">
<title><![CDATA[Alexithymia Is Associated With Increased Cardiovascular Mortality in Middle-Aged Finnish Men]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/187?rss=1</link>
<description><![CDATA[
<p><b>Objective: </b> To explore the associations between alexithymia and increased somatic morbidity. The mechanisms underlying these associations, however, are still unclear. Furthermore, data on the association between alexithymia and mortality are scarce.</p>
<p><b>Methods: </b> A total of 2321 Finnish men, aged 46 to 61 years, were followed up for an average of 20 years. Mortality rates were obtained from the national register. The associations between baseline alexithymia and cardiovascular disease (CVD), all-cause, injury, and cancer deaths were examined with adjustments for age and several behavioral (smoking, alcohol consumption, physical activity), physiological (low- and high-density lipoprotein cholesterol, body mass index, systolic blood pressure, history of CVD), and psychosocial (marital status, education, depression) factors.</p>
<p><b>Results: </b> After all adjustments, the risk of CVD death was increased by 1.2% for each 1-point increase in Toronto Alexithymia Scale-26 scores.</p>
<p><b>Conclusions: </b> Alexithymia is associated with increased cardiovascular mortality.</p>
]]></description>
<dc:creator><![CDATA[Tolmunen, T., Lehto, S. M., Heliste, M., Kurl, S., Kauhanen, J.]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Personality, Other Cardiovascular Medicine]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181c65d00</dc:identifier>
<dc:title><![CDATA[Alexithymia Is Associated With Increased Cardiovascular Mortality in Middle-Aged Finnish Men]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>191</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>187</prism:startingPage>
<prism:section>ORIGINAL ARTICLES</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/192?rss=1">
<title><![CDATA[Conditioned Pharmacotherapeutic Effects: A Preliminary Study]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/192?rss=1</link>
<description><![CDATA[
<p><b>Objective: </b> To test the hypothesize that psoriasis patients treated under a partial schedule of pharmacologic (corticosteroid) reinforcement would show less severe symptoms and relapse than those given the same amount of drug under standard conditions. Behavioral conditioning as an inherent component of many pharmacotherapeutic protocols has never been examined.</p>
<p><b>Methods: </b> A double-blind, simple randomization intervention was conducted with 46 patients from California and New York. Initially, lesions were treated with 0.1% acetonide triamcinolone under standard treatment conditions. Thereafter, a Standard Therapy group continued on continuous reinforcement (active drug every treatment) with 100% of the initial dose; Partial Reinforcement patients received a full dose 25% to 50% of the time and placebo medication other times; Dose Control patients received continuous reinforcement with 25% to 50% of the initial dose.</p>
<p><b>Results: </b> Severity of disease scores in California neither supported nor refuted the hypothesis. In New York, where there was no difference between Partial Reinforcement and Dose Control groups at baseline, partial reinforcement effected a greater reduction in lesion severity than Dose Control conditions and did not differ from Standard Therapy patients receiving two to four times more drug. For the entire population, the frequency of relapse under partial reinforcement (26.7%) was lower than in Dose Control patients (61.5%) and did not differ from full-dose treatment (22.2%).</p>
<p><b>Conclusions: </b> A partial schedule of pharmacotherapeutic reinforcement could maintain psoriasis patients with a cumulative amount of corticosteroid that was relatively ineffective when administered under standard treatment conditions. Conceivably, corticosteroid administration only one quarter or half as frequently as currently prescribed is sufficient to treat psoriasis. We posit, however, that these preliminary observations implicate conditioning processes in&mdash;and for the design of&mdash;regimens of pharmacotherapy.</p>
]]></description>
<dc:creator><![CDATA[Ader, R., Mercurio, M. G., Walton, J., James, D., Davis, M., Ojha, V., Kimball, A. B., Fiorentino, D.]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Dermatology, Health Psychology, Therapeutic Interventions]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181cbd38b</dc:identifier>
<dc:title><![CDATA[Conditioned Pharmacotherapeutic Effects: A Preliminary Study]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>197</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>192</prism:startingPage>
<prism:section>ORIGINAL ARTICLES</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/198?rss=1">
<title><![CDATA[Trait Anxiety Predicts Unsuccessful Surgery in Gallstone Disease]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/198?rss=1</link>
<description><![CDATA[
<p><b>Objective: </b> To identify predictors of negative symptomatic outcomes at 6 months after cholecystectomy, surgical removal of the gallbladder, which is the preferred treatment for gallstone disease. After cholecystectomy, a substantial number of patients report persistence of symptoms.</p>
<p><b>Methods: </b> In this prospective follow-up study, consecutive patients (<I>n</I> = 172) diagnosed with symptomatic gallstone disease and indicated for elective cholecystectomy were investigated. Preoperatively and at 6 months, patients completed self-report symptom checklists. The Spielberger State-Trait Anxiety Inventory scale was completed preoperatively and patients with a score of &ge; P 80 were considered having High Trait Anxiety (HTA). Multivariate regression analyses were used to investigate independent predictors of persisting symptoms.</p>
<p><b>Results: </b> Six months after cholecystectomy, patients with HTA were more likely to report persisting biliary symptoms than patients without HTA (NHTA) (45.5% versus 14.3%; <sup>2</sup> = 8.78, <I>p</I> = .002). HTA was identified as an independent predictor of persisting biliary symptoms at 6 months (odds ratio [OR], 3.08, <I>p</I> = .047; 95% confidence interval [CI], 1.02&ndash;9.34), in addition to the report of nonspecific symptoms (OR, 6.16, <I>p</I> = .024; 95% CI, 1.27&ndash;29.82), and the use of psychotropic medication (OR, 4.76, <I>p</I> = .023; 95% CI, 1.24&ndash;18.34).</p>
<p><b>Conclusion: </b> Patients with HTA have a three times higher risk at persisting biliary symptoms at 6 months after cholecystectomy than NHTA patients. Both clinical factors and the patient&rsquo;s personality should be considered in clinical decision making and risk estimation in elective cholecystectomy.</p>
]]></description>
<dc:creator><![CDATA[Mertens, M. C., Roukema, J. A., Scholtes, V. P. W., De Vries, J.]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Personality, Anxiety]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181cb65b4</dc:identifier>
<dc:title><![CDATA[Trait Anxiety Predicts Unsuccessful Surgery in Gallstone Disease]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>205</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>198</prism:startingPage>
<prism:section>ORIGINAL ARTICLES</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/206?rss=1">
<title><![CDATA[Caffeine Consumption and Cognitive Function at Age 70: The Lothian Birth Cohort 1936 Study]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/206?rss=1</link>
<description><![CDATA[
<p><b>Objective: </b> To investigate the association between caffeine consumption and cognitive outcomes in later life.</p>
<p><b>Methods: </b> Participants were 923 healthy adults from the Lothian Birth Cohort 1936 Study, on whom there were intelligence quotient (IQ) data from age 11 years. Cognitive function at age 70 years was assessed, using tests measuring general cognitive ability, speed of information processing, and memory. Current caffeine consumption (using multiple measures of tea, coffee, and total dietary caffeine) was obtained by self-report questionnaire, and demographic and health information was collected in a standardized interview.</p>
<p><b>Results: </b> In age- and sex-adjusted models, there were significant positive associations between total caffeine intake and general cognitive ability and memory. After adjustment for age 11 IQ and social class, both individually and together, most of these associations became nonsignificant. A robust positive association, however, was found between drinking ground coffee (e.g., filter and espresso) and performance on the National Adult Reading Test (NART, <I>p</I> = .007), and the Wechsler Test of Adult Reading (WTAR, <I>p</I> = .02). No gender effects were observed, contrary to previous studies. Generally, higher cognitive scores were associated with coffee consumption, and lower cognitive scores with tea consumption, but these effects were not significant in the fully adjusted model.</p>
<p><b>Conclusions: </b> The present study is rare in having childhood IQ in a large sample of older people. The results suggest that the significant caffeine intake-cognitive ability associations are bidirectional&mdash;because childhood IQ and estimated prior IQ are associated with the type of caffeine intake in old age&mdash;and partly confounded by social class.</p>
]]></description>
<dc:creator><![CDATA[Corley, J., Jia, X., Kyle, J. A. M., Gow, A. J., Brett, C. E., Starr, J. M., McNeill, G., Deary, I. J.]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Aging, Nutrition, Cognitive Functioning]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181c92a9c</dc:identifier>
<dc:title><![CDATA[Caffeine Consumption and Cognitive Function at Age 70: The Lothian Birth Cohort 1936 Study]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>214</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>206</prism:startingPage>
<prism:section>ORIGINAL ARTICLES</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/215?rss=1">
<title><![CDATA[Childhood Abuse Is Associated With Adiposity in Midlife Women: Possible Pathways Through Trait Anger and Reproductive Hormones]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/215?rss=1</link>
<description><![CDATA[
<p><b>Objective: </b> To examine the association between childhood abuse/neglect and central adiposity and obesity in a sample of 311 women (<I>n</I> = 106 black, 205 white) from the Pittsburgh site of the Study of Women&rsquo;s Health Across the Nation (SWAN).</p>
<p><b>Methods: </b> SWAN included a baseline measurement of women in midlife (mean age = 45.7 years) and eight follow-up visits during which waist circumference (WC) and body mass index (BMI) were measured. The Childhood Trauma Questionnaire retrospectively assessed emotional, physical, and sexual abuse, and emotional and physical neglect in childhood.</p>
<p><b>Results: </b> Analyses of covariance showed that women with a history of any abuse/neglect, and specifically physical and sexual abuse, had significantly higher WC and BMI at baseline than women with no abuse history. A significant interaction between abuse and BMI showed that among women with BMI of &lt;30, any abuse/neglect and certain subtypes of abuse predicted greater increases in WC over time. Additional analyses showed that Trait Anger scores and sex hormone-binding globulin (SHBG) attenuated cross-sectional relationships between abuse/neglect and WC and BMI.</p>
<p><b>Conclusion: </b> This study suggests that abused/neglected women seem to have greater anger and lower levels of SHBG, which are associated with adiposity in midlife.</p>
]]></description>
<dc:creator><![CDATA[Midei, A. J., Matthews, K. A., Bromberger, J. T.]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Social Support, Pediatrics, Overweight or Obesity]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181cb5c24</dc:identifier>
<dc:title><![CDATA[Childhood Abuse Is Associated With Adiposity in Midlife Women: Possible Pathways Through Trait Anger and Reproductive Hormones]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>223</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>215</prism:startingPage>
<prism:section>ORIGINAL ARTICLES</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/224?rss=1">
<title><![CDATA[THEORIES OF DEPRESSION AND ANXIETY AND CARDIOVASCULAR OUTCOMES IN PSYCHOSOMATIC MEDICINE AND BEHAVIORAL CARDIOLOGY]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/224?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Tully, P. J.]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:subject><![CDATA[Depression, Letters to the Editor, Other Cardiovascular Medicine]]></dc:subject>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181d27b79</dc:identifier>
<dc:title><![CDATA[THEORIES OF DEPRESSION AND ANXIETY AND CARDIOVASCULAR OUTCOMES IN PSYCHOSOMATIC MEDICINE AND BEHAVIORAL CARDIOLOGY]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>225</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>224</prism:startingPage>
<prism:section>LETTERS TO THE EDITOR</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/226?rss=1">
<title><![CDATA[Psychosomatic Medicine Reviewers: January 1, 2009, through December 31, 2009]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/226?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:identifier>info:doi/10.1097/PSY.0b013e3181d3a45a</dc:identifier>
<dc:title><![CDATA[Psychosomatic Medicine Reviewers: January 1, 2009, through December 31, 2009]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>227</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>226</prism:startingPage>
<prism:section>REVIEWERS</prism:section>
</item>

<item rdf:about="http://www.psychosomaticmedicine.org/cgi/content/short/72/2/227?rss=1">
<title><![CDATA[Recent Deaths of American Psychosomatic Society Members]]></title>
<link>http://www.psychosomaticmedicine.org/cgi/content/short/72/2/227?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Tue, 09 Feb 2010 14:38:03 PST</dc:date>
<dc:identifier>info:doi/10.1097/01.psy.0000368542.45824.20</dc:identifier>
<dc:title><![CDATA[Recent Deaths of American Psychosomatic Society Members]]></dc:title>
<dc:publisher>American Psychosomatic Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>72</prism:volume>
<prism:endingPage>227</prism:endingPage>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:startingPage>227</prism:startingPage>
<prism:section>IN MEMORIAM</prism:section>
</item>

</rdf:RDF>